# Minoryx Therapeutics SL

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/minoryx-therapeutics-sl

- Industry: Biotechnology
- Headquarters: Barcelona, Spain
- Website: www.minoryx.com
- Total disclosed funding: $94M
- Latest round: Series C (Apr 8, 2022)
- Investors on record: 15

## About

Based in Barcelona, Spain, and founded in 2011, Minoryx Therapeutics SL operates as a biotechnology company that develops small-molecule drugs. The company was founded by its CEO, Marc Martinell, Xavier Barril, and Joan Aymamí. In May 2022, Minoryx Therapeutics SL raised venture debt financing from unspecified investors. The round was part of a larger EUR 51 million series C and debt financing.

Minoryx Therapeutics develops novel therapies for diseases affecting the CNS, including X-linked adrenoleukodystrophy (X-ALD) and Friedreich's ataxia (FRDA). The company's pipeline project includes a marketing authorization application (MAA) for the development of leriglitazone (MIN-102), a PPAR gamma agonist. This drug candidate has been developed for the treatment of adult male X-ALD patients with AMN, a neurodegenerative disease that exists in two forms: a chronic form, AMN, and an acute form, cerebral ALD (cALD).

The company plans to use the funds raised in May 2022 to support the regulatory process for male patients in AMN, launch compounds in Europe, and carry out the necessary activities in the US regulatory pathway.

## Funding rounds

- Series C, Apr 8, 2022, $43M — Ysios Capital Partners, Caixa Capital Risc, Fund+, Columbus Venture Partners, Center for Technological & Industrial Development
- Series B, Sep 25, 2018, $25M — Idinvest Partners, Riva y Garcia Private Equity, Ysios Capital Partners, Société Régionale d'Investissement de Wallonie, Kurma Partners, Roche Venture Fund, Caixa Capital Risc, SFPI-FPIM, Sambrinvest, Chiesi Ventures, Fund+
- Series A, Oct 13, 2015, $22M — Idinvest Partners, Riva y Garcia Private Equity, Ysios Capital Partners, Kurma Partners, Roche Venture Fund, Caixa Capital Risc, Chiesi Ventures
- Series B, Jan 23, 2015, $1.9M — Caixa Capital Risc, Foundation Sanfilippo
- Series A, Apr 2, 2013, $2M — Inveready Asset Management, Caixa Capital Risc

## Investors

- Inveready Asset Management (https://capitalatlas.ai/funds/inveready-asset-management) — Series A
- Caixa Capital Risc — Series A, Series B, Series C
- Foundation Sanfilippo — Series B
- Idinvest Partners (https://capitalatlas.ai/funds/idinvest-partners) — Series A, Series B
- Riva y Garcia Private Equity (https://capitalatlas.ai/funds/riva-y-garcia-private-equity) — Series A, Series B
- Ysios Capital Partners (https://capitalatlas.ai/funds/ysios-capital-partners) — Series A, Series B, Series C
- Kurma Partners (https://capitalatlas.ai/funds/kurma-partners) — Series A, Series B
- Roche Venture Fund (https://capitalatlas.ai/funds/roche-venture-fund) — Series A, Series B
- Chiesi Ventures (https://capitalatlas.ai/funds/chiesi-ventures) — Series A, Series B
- Société Régionale d'Investissement de Wallonie — Series B
- SFPI-FPIM — Series B
- Sambrinvest (https://capitalatlas.ai/funds/sambrinvest) — Series B
- Fund+ (https://capitalatlas.ai/funds/fund) — Series B, Series C
- Columbus Venture Partners (https://capitalatlas.ai/funds/columbus-venture-partners) — Series C
- Center for Technological & Industrial Development (https://capitalatlas.ai/funds/center-for-technological-industrial-development) — Series C